385 related articles for article (PubMed ID: 8179182)
21. Growth factor regulation of the amylase promoter in a differentiating salivary acinar cell line.
Zheng C; Hoffman MP; McMillan T; Kleinman HK; O'Connell BC
J Cell Physiol; 1998 Dec; 177(4):628-35. PubMed ID: 10092215
[TBL] [Abstract][Full Text] [Related]
22. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase.
Glaser KB; Li J; Aakre ME; Morgan DW; Sheppard G; Stewart KD; Pollock J; Lee P; O'Connor CZ; Anderson SN; Mussatto DJ; Wegner CW; Moses HL
Mol Cancer Ther; 2002 Aug; 1(10):759-68. PubMed ID: 12492108
[TBL] [Abstract][Full Text] [Related]
24. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
Thalacker FW; Nilsen-Hamilton M
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
[TBL] [Abstract][Full Text] [Related]
25. Interaction of specifically chemically modified dextrans with transforming growth factor beta1: potentiation of its biological activity.
Logeart-Avramoglou D; Huynh R; Chaubet F; Sedel L; Meunier A
Biochem Pharmacol; 2002 Jan; 63(2):129-37. PubMed ID: 11841786
[TBL] [Abstract][Full Text] [Related]
26. Bovine chromaffin cells release a transforming growth factor-beta-like molecule contained within chromaffin granules.
Krieglstein K; Unsicker K
J Neurochem; 1995 Sep; 65(3):1423-6. PubMed ID: 7643124
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells.
Sandberg T; Eriksson P; Gustavsson B; Casslén B
Mol Hum Reprod; 1997 Sep; 3(9):781-7. PubMed ID: 9358004
[TBL] [Abstract][Full Text] [Related]
28. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway.
Ming M; Ewen ME; Pereira ME
Cell; 1995 Jul; 82(2):287-96. PubMed ID: 7628017
[TBL] [Abstract][Full Text] [Related]
29. Requirements for transforming growth factor-beta regulation of the pro-alpha 2(I) collagen and plasminogen activator inhibitor-1 promoters.
Chang E; Goldberg H
J Biol Chem; 1995 Mar; 270(9):4473-7. PubMed ID: 7876214
[TBL] [Abstract][Full Text] [Related]
30. The human plasminogen activator inhibitor type I gene promoter targets to kidney.
Emert MP; Sorenson CM; Basile DP; Rogers JG; Hammerman MR; Billadello JJ
Am J Physiol; 1998 Feb; 274(2):F405-12. PubMed ID: 9486236
[TBL] [Abstract][Full Text] [Related]
31. [Ser77]transforming growth factor-beta 1. Selective biological activity and receptor binding in mink lung epithelial cells.
Amatayakul-Chantler S; Qian SW; Gakenheimer K; Böttinger EP; Roberts AB; Sporn MB
J Biol Chem; 1994 Nov; 269(44):27687-91. PubMed ID: 7961688
[TBL] [Abstract][Full Text] [Related]
32. Characterization of mutated transforming growth factor-beta s which possess unique biological properties.
Qian SW; Burmester JK; Sun PD; Huang A; Ohlsen DJ; Suardet L; Flanders KC; Davies D; Roberts AB; Sporn MB
Biochemistry; 1994 Oct; 33(40):12298-304. PubMed ID: 7918451
[TBL] [Abstract][Full Text] [Related]
33. Establishment of cell-based reporter system for diagnosis of poxvirus infection.
Levy O; Oron C; Paran N; Keysary A; Israeli O; Yitzhaki S; Olshevsky U
J Virol Methods; 2010 Jul; 167(1):23-30. PubMed ID: 20307573
[TBL] [Abstract][Full Text] [Related]
34. A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection.
Rogier E; Durrbach A; Abecassis L; Ferlicot S; Snanoudj R; Baudreuil S; Arzouk N; Vazquez A; Charpentier B; Bourgeade MF
Kidney Int; 2005 Oct; 68(4):1875-83. PubMed ID: 16164666
[TBL] [Abstract][Full Text] [Related]
35. Optimisation of CCL64-based bioassay for TGF-beta.
Garrigue-Antar L; Barbieux I; Lieubeau B; Boisteau O; Grégoire M
J Immunol Methods; 1995 Oct; 186(2):267-74. PubMed ID: 7594626
[TBL] [Abstract][Full Text] [Related]
36. In vitro bioassay for transforming growth factor-beta using XTT method.
Kim MS; Ahn SM; Moon A
Arch Pharm Res; 2002 Dec; 25(6):903-9. PubMed ID: 12510846
[TBL] [Abstract][Full Text] [Related]
37. Complex cytokine modulation of a continuous line of mink lung epithelial cells (Mv1Lu).
Kelley J; Baldor L; Absher M
Exp Lung Res; 1992; 18(6):877-87. PubMed ID: 1468414
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling.
Hocevar BA; Howe PH
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7655-60. PubMed ID: 8755531
[TBL] [Abstract][Full Text] [Related]
39. Measurement of TGF-beta in biological fluids.
Hale-Donze H; Wahl SM; Jackson RJ; McGhee JR
Curr Protoc Immunol; 2001 May; Chapter 6():Unit 6.11. PubMed ID: 18432803
[TBL] [Abstract][Full Text] [Related]
40. Highly sensitive and specific bioassay for measuring bioactive TGF-beta.
Tesseur I; Zou K; Berber E; Zhang H; Wyss-Coray T
BMC Cell Biol; 2006 Mar; 7():15. PubMed ID: 16549026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
